Current status and future perspectives of FGF21 ...
Recent advances in fibroblast growth factor 21 ( FGF21 ) biology and pharmacology have led to the development of several long-acting FGF21 analogues and antibody-based mimetics now in various phases of clinical trials for the treatment of obesity-related metabolic comorbidities.
Recent advances in fibroblast growth factor 21 ( FGF21 ) biology and pharmacology have led to the development of several long-acting FGF21 analogues and antibody-based mimetics now in various phases of clinical trials for the treatment of obesity-related metabolic comorbidities. The efficacy of these FGF21 analogues/mimetics on glycaemic control and weight loss is rather mild and inconsistent ...
Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders
Non-FGF-Based Analogs While significant improvements have been made to FGF21 and other FGF-based FGF21 analogs, additional challenges may need to be addressed as the molecules progress through development. For example, potential induction of anti -drug antibodies that neutralize endogenous ligand function may pose risk in the clinic.
Fibroblast growth factor 21 ( FGF21 ), a member of the fibroblast growth factor family, plays a positive and protective role in MASLD. It attenuates hepatic steatosis and lipotoxicity, ameliorates insulin resistance (IR), reduces oxidative stress, endoplasmic reticulum (ER) stress, and inflammation, as well as possesses anti -fibrotic effects.
Here, we have identified tumor-secreted fibroblast growth factor 21 ( FGF21 ) as a pivotal immune suppressor. FGF21 is upregulated in multiple types of tumors and promotes tumor progression. Tumor-secreted FGF21 significantly disrupts anti -tumor immunity by rewiring cholesterol metabolism of CD8 + T cells.
Fibroblast Growth Factor 21 Exerts Direct Anti -Fibrotic Effects FGF21 and its analogs have demonstrated consistent anti -fibrotic effects in cell culture systems and animal models of NASH, liver injury, or metabolic disease.
FGF21 agonists
Fibroblast growth factor ( FGF ) 21 is a stress-induced 181 amino acid hormone produced in the liver and other metabolically active tissues. FGF21 is primarily secreted from the liver and adipose tissue, which regulates energy homeostasis and has pleiotropic metabolic effects. The secretion of FGF21 is induced by several extrinsic stressors such as exercise, fasting, protein deficiency, high ...
FGF21 and cardiovascular and metabolic diseases. Current studies support that FGF21 plays an important role in cardiovascular and metabolic diseases. Nonalcoholic fatty liver disease (NAFLD); nonalcoholic steatohepatitis (NASH). FGF21 , a signaling protein of 208 amino acids, belongs to the fibroblast growth factor (FGF) family 5.
A Novel Recombinant Human FGF21 Analog with High Glycosylation ...
Fibroblast growth factor 21 ( FGF21 ), a hormone-like protein, plays a crucial role in enhancing glucose and lipid metabolism, offering promising therapeutic avenues for conditions such as nonalcoholic steatohepatitis and severe hypertriglyceridemia. Despite its potential, this protein's limited stability and brief half-life pose significant challenges for its use in clinical settings. In this ...
Fibroblast growth factor 21 ( FGF-21 ) is a protein found in humans and other mammals that is encoded by the FGF21 gene. [5][6] This protein is a member of the fibroblast growth factor (FGF) family and its endocrine subfamily along with FGF23 and FGF15/19.
